Journal of Antimicrobial Chemotherapy, 1460-2091

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Defining optimal dosing of ciprofloxacin in patients with septic shock

    Roberts, J. A., Alobaid, A. S., Wallis, S. C., Perner, A., Lipman, J. & Fredrik Sjövall, 2019, I : The Journal of antimicrobial chemotherapy. 74, 6, s. 1662-1669 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2018
  4. Maximally effective dosing regimens of meropenem in patients with septic shock

    Fredrik Sjövall, Alobaid, A. S., Wallis, S. C., Perner, A., Lipman, J. & Roberts, J. A., 2018 jan 1, I : Journal of Antimicrobial Chemotherapy. 73, 1, s. 191-198 8 s., dkx330.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions

    Jensen, J. N., Eva Melander, Katarina Hedin, Bjerrum, L., Helena Kornfält Isberg, Holm, A., Jacobsen, H. N., Skovby, A., Currea, G. C. C., Hyllebusk, L., Brogaard, E. & Arpi, M., 2018, I : Journal of Antimicrobial Chemotherapy. 73, 8, s. 2207-2214 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2016
  7. Impact of amoxicillin therapy on resistance selection in patients with community-acquired lower respiratory tract infections: A randomized, placebo-controlled study

    GRACE study group, 2016 nov 1, I : Journal of Antimicrobial Chemotherapy. 71, 11, s. 3258-3267 10 s., dkw234.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Lambert-Niclot, S., George, E. C., Pozniak, A., White, E., Schwimmer, C., Jessen, H., Johnson, M., Dunn, D., Perno, C. F., Clotet, B., Plettenberg, A., Blaxhult, A., Palmisano, L., Wittkop, L., Calvez, V., Marcelin, A. G., Raffi, F., Dedes, N., Chěne, G., Allavena, C. & 31 andra, Autran, B., Antinori, A., Bucciardini, R., Vella, S., Horban, A., Arribas, J., Babiker, A. G., Boffito, M., Pillay, D., Pozniak, A., Franquet, X., Schwarze, S., Grarup, J., Fischer, A., Richert, L., Wallet, C., Raffi, F., Diallo, A., Molina, J-M., Saillard, J., Moecklinghoff, C., Stellbrink, H-J., Van Leeuwen, R., Gatell, J., Sandstrom, E., Flepp, M., Ewings, F., George, E. C., Hudson, F., Michal Odermarsky & on behalf of the NEAT 001/ANRS 143 Study Group, 2016 apr 1, I : Journal of Antimicrobial Chemotherapy. 71, 4, s. 1056-1062 7 s., dkv427.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection.

    Praveen Papareddy, Kasetty, G., Kalle, M., Ravi Bhongir, Mörgelin, M., Artur Schmidtchen & Malmsten, M., 2016, I : Journal of Antimicrobial Chemotherapy. 71, 1, s. 170-180

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. 2014
  11. Group A streptococci are protected from amoxicillin-mediated killing by vesicles containing β-lactamase derived from Haemophilus influenzae.

    Schaar, V., Uddbäck, I., Nordström, T. & Kristian Riesbeck, 2014, I : Journal of Antimicrobial Chemotherapy. 69, 1, s. 117-120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Prevalence, distribution and transfer of small β-lactamase-containing plasmids in Swedish Haemophilus influenzae.

    Fleury, C., Fredrik Resman, Rau, J. & Kristian Riesbeck, 2014, I : Journal of Antimicrobial Chemotherapy. 69, 5, s. 1238-1242

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2013
  14. Outer membrane vesicles shield Moraxella catarrhalis β-lactamase from neutralization by serum IgG.

    Schaar, V., Magnus Paulsson, Mörgelin, M. & Kristian Riesbeck, 2013, I : Journal of Antimicrobial Chemotherapy. 68, 3, s. 593-600

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2012
  16. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.

    Holmberg, A., Mörgelin, M. & Magnus Rasmussen, 2012, I : Journal of Antimicrobial Chemotherapy. 67, s. 433-439

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. The epithelium-produced growth factor midkine has fungicidal properties.

    Nordin, S., Sonesson, A., Malmsten, M., Mörgelin, M. & Arne Egesten, 2012, I : Journal of Antimicrobial Chemotherapy. 67, 8, s. 1927-1936

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 2010
  19. Combinations of maggot excretions/secretions and antibiotics are effective against Staphylococcus aureus biofilms and the bacteria derived therefrom

    Mariena J.A. van der Plas, Dambrot, C., Dogterom-Ballering, H. C. M., Kruithof, S., van Dissel, J. T. & Nibbering, P. H., 2010 feb 26, I : Journal of Antimicrobial Chemotherapy. 65, 5, s. 917-923 7 s., dkq042.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

    Angeby, K. A., Jureen, P., Giske, C. G., Chryssanthou, E., Erik Sturegård, Nordvall, M., Johansson, A. G., Werngren, J., Kahlmeter, G., Hoffner, S. E. & Schon, T., 2010, I : Journal of Antimicrobial Chemotherapy. 65, 5, s. 946-952

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2009
  22. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

    Schon, T., Jureen, P., Giske, C. G., Chryssanthou, E., Erik Sturegård, Werngren, J., Kahlmeter, G., Hoffner, S. E. & Angeby, K. A., 2009, I : Journal of Antimicrobial Chemotherapy. 64, 4, s. 786-793

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2008
  24. Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa

    Mariena J.A. Van der Plas, Jukema, G. N., Wai, S. W., Dogterom-Ballering, H. C. M., Lagendijk, E. I., Van Gulpen, C., Van Dissel, J. T., Bloemberg, G. V. & Nibbering, P. H., 2008 jan, I : Journal of Antimicrobial Chemotherapy. 61, 1, s. 117-122 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2007
  26. Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner

    Sandrini, M. P. B., Clausen, A. R., On, S. L. W., Aarestrup, F. M., Munch-Petersen, B. & Piskur, J., 2007, I : Journal of Antimicrobial Chemotherapy. 60, 3, s. 510-520

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2006
  28. Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation

    Kronvall, G., Karlsson, I., Mats Walder, Sorberg, M. & Nilsson, LE., 2006, I : Journal of Antimicrobial Chemotherapy. 57, 3, s. 498-505

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids

    Baranska-Rybak, W., Sonesson, A., Nowicki, R. & Artur Schmidtchen, 2006, I : Journal of Antimicrobial Chemotherapy. 57, 2, s. 260-265

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. 2005
  31. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry

    Pina-Vaz, C., Rodrigues, AG., Costa-de-Oliveira, S., Ricardo, E. & Per-Anders Mårdh, 2005, I : Journal of Antimicrobial Chemotherapy. 56, 4, s. 678-685

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2004
  33. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

    Kruszewska, D., Sahl, H-G., Bierbaum, G., Pag, U., Hynes, S. & Ljungh, Å., 2004, I : Journal of Antimicrobial Chemotherapy. 54, 3, s. 648-653

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer

    Werthen, M., Davoudi, M., Sonesson, A., Nitsche, P., Mörgelin, M., Blom, K. & Artur Schmidtchen, 2004, I : Journal of Antimicrobial Chemotherapy. 54, 4, s. 772-779

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2002
  36. The treatment of Haemophilus influenzae acute otitis media with amoxicillin protects against reinfection but not against structural changes

    Westman, E. & Melhus, Å., 2002, I : Journal of Antimicrobial Chemotherapy. 49, 1, s. 141-147

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. 1998
  38. Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol

    Abate, G. & Miörner, H., 1998, I : Journal of Antimicrobial Chemotherapy. 42, 6, s. 735-740

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. 1996
  40. Identification of mecA-related oxacillin resistance in staphylococci by the E test and the broth microdilution method

    Petersson, A. C., Miörner, H. & Kamme, C., 1996, I : Journal of Antimicrobial Chemotherapy. 37, 3, s. 445-456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. 1993
  42. Recurrent episodes of thrombocytopenia during treatment with sodium stibogluconate

    Braconier, J. H. & Miörner, H., 1993, I : Journal of Antimicrobial Chemotherapy. 31, 1, s. 187-188

    Forskningsoutput: TidskriftsbidragLetter